tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
TBPH is currently covered by 6 analysts with an average price target of $22.98. This is a potential upside of $6.38 (38.43%) from yesterday's end of day stock price of $16.6.
Theravance Biopharma's activity chart (see below) currently has 103 price targets and 106 ratings on display. The stock rating distribution of TBPH is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 59.78% with an average time for these price targets to be met of 341.13 days.
Highest price target for TBPH is $21, Lowest price target is $13, average price target is $15.6.
Most recent stock forecast was given by MARC FRAHM from TD COWEN on 23-Mar-2026. First documented stock forecast 03-Feb-2015.
Currently out of the existing stock ratings of TBPH, 15 are a BUY (83.33%), 3 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Sep-2021
$15
$-1.02 (-6.37%)
$13
17 days ago
(23-Mar-2026)
9/10 (90%)
$0.25 (1.69%)
232
Buy Since 12-Apr-2024
$21
$4.98 (31.09%)
$21
20 days ago
(20-Mar-2026)
0/9 (0%)
$6.67 (46.55%)
Buy Since 29-Oct-2019
$15
$-1.02 (-6.37%)
$27
1 months 5 days ago
(04-Mar-2026)
12/14 (85.71%)
$1.33 (9.73%)
519
Buy Since 04-Mar-2026
$14
$-2.02 (-12.61%)
$28
1 months 5 days ago
(04-Mar-2026)
1/2 (50%)
$0.33 (2.41%)
5
Hold Since 13-Nov-2024
$13
$-3.02 (-18.85%)
$10
7 months 27 days ago
(13-Aug-2025)
5/5 (100%)
$0.58 (4.67%)
471
What is TBPH (Theravance Biopharma) average time for price targets to be met?
Which analyst has the current highest performing score on TBPH (Theravance Biopharma) with a proven track record?
Which analyst has the most public recommendations on TBPH (Theravance Biopharma)?
Which analyst is the currently most bullish on TBPH (Theravance Biopharma)?
Which analyst is the currently most reserved on TBPH (Theravance Biopharma)?
